Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 21 Oct 2024 17:45 CEST |
SYENSQO | Syensqo - Verwerving van eigen aandelen | 55101000 Diversified Materials | Change in Capital |
| 21 Oct 2024 17:45 CEST |
KUMULUS VAPE | ESG : Kumulus Vape maintient sa classification "Argent" | 40401030 Specialty Retailers | Legal |
| 21 Oct 2024 17:45 CEST |
SYENSQO | Syensqo - Acquisition of own shares | 55101000 Diversified Materials | Change in Capital |
| 21 Oct 2024 17:45 CEST |
VALNEVA SE | Valneva effectuera des présentations sur le chikungunya lors de différentes conférences scientifiques de premier plan | 20103015 Pharmaceuticals | Products and services |
| 21 Oct 2024 17:45 CEST |
BONDUELLE | Bonduelle - Statement of availability of 2023-2024 Universal Registration Document | 45102020 Food Products | Income |
| 21 Oct 2024 17:40 CEST |
AGEAS | Rapport d’Ageas sur le programme de rachat d’actions | 30301010 Life Insurance | Other financial transaction |
| 21 Oct 2024 17:40 CEST |
SIGNAUX GIROD | Signaux Girod : Déclaration rachat actions propres semaine 42/2024 | 50204000 Machinery: Industrial | Share history |
| 21 Oct 2024 17:40 CEST |
AGEAS | Ageas rapporteert over de inkoop van eigen aandelen | 30301010 Life Insurance | Other financial transaction |
| 21 Oct 2024 17:40 CEST |
AGEAS | Ageas reports on the progress of share buy-back programme | 30301010 Life Insurance | Other financial transaction |
| 21 Oct 2024 17:38 CEST |
L'OREAL | Disclosure of total number of voting rights and number of shares in the capital at September 30, 2024 | 40204035 Cosmetics | Other subject |
| 21 Oct 2024 17:38 CEST |
L'OREAL | Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 septembre 2024 | 40204035 Cosmetics | Other subject |
| 21 Oct 2024 17:35 CEST |
PYRUM INNOVATIONS AG | AdHoc: Pyrum Innovations AG resolves cash capital increase from authorised capital with exclusion of subscription rights | 65103035 Waste and Disposal Services | Inside information |
| 21 Oct 2024 17:35 CEST |
EURAZEO SE | Disclosure of transactions in own shares on October 14 to October 18, 2024 | 30202010 Asset Managers and Custodians | Other subject |
| 21 Oct 2024 17:35 CEST |
EURAZEO SE | Déclaration hebdomadaire d\'opérations effectuées du 14 au 18 octobre 2024 | 30202010 Asset Managers and Custodians | Other subject |
| 21 Oct 2024 17:35 CEST |
ASSYSTEM | Programme de rachat d'actions propres - Déclaration des transactions sur actions propres réalisées du 14 octobre 2024 au 18 octobre 2024 | 50101015 Engineering and Contracting Services | Share history |
| 21 Oct 2024 17:27 CEST |
LIFECARE ASA | LIFE Lifecare ASA uplisting to Euronext Oslo Børs is approved | 20103010 Biotechnology | Non-regulatory press releases |
| 21 Oct 2024 17:00 CEST |
VISTIN PHARMA | Responsibility statement for first half year of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 21 Oct 2024 16:53 CEST |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Mandatory notification of trade | 45102020 Food Products | Mandatory notification of trade primary insiders |
| 21 Oct 2024 16:53 CEST |
ARCTIC BIOSCIENCE AS | Arctic Bioscience - Meldepliktig handel | 45102020 Food Products | Meldepliktig handel for primærinnsidere |
| 21 Oct 2024 16:35 CEST |
AEGA | AEGA ASA - Mandatory notification of sale of shares by primary insider | 30202000 Diversified Financial Services | Mandatory notification of trade primary insiders |
| 21 Oct 2024 16:15 CEST |
EVERFUEL | EXTENSION OF THE OFFER PERIOD FOR THE UNREGULATED RECOMMENDED VOLUNTARY CASH OFFER OF NOK 13 PER SHARE TO THE SHAREHOLDERS OF EVERFUEL A/S FOLLOWING RECEIPT OF ACCEPTANCES REPRESENTING MORE THAN 90% | 60102010 Alternative Fuels | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 16:14 CEST |
BlueNord ASA | Major Holding Notification form BLUENORD ASA | 60101010 Oil: Crude Producers | Major shareholding notifications |
| 21 Oct 2024 16:00 CEST |
SpareBank 1 Nord-Norge | SpareBank 1 Nord-Norge is presenting 3rd quarter 2024 accounts | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 16:00 CEST |
SpareBank 1 Nord-Norge | SpareBank 1 Nord-Norge inviterer til resultatpresentasjon for 3. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
| 21 Oct 2024 15:59 CEST |
BENCHMARK HOLDINGS PLC | Financial calendar | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 15:59 CEST |
BENCHMARK HOLDINGS PLC | Finansiell kalender | 20103010 Biotechnology | Annen informasjonspliktig regulatorisk informasjon |
| 21 Oct 2024 15:54 CEST |
SCOR SE | Déclaration des transactions sur actions propres réalisées le 18 octobre 2024 | 30302020 Reinsurance | Share history |
| 21 Oct 2024 15:45 CEST |
AQUA BIO TECHNOLOGY | Financial calendar | 45201020 Personal Products | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 15:45 CEST |
Citycon Treasury B.V. | Notice to the Extraordinary General Meeting of Citycon Oyj | - | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 15:38 CEST |
Olav Thon Eiendomsselskap ASA | PRESENTASJON AV RESULTATENE FOR 3. KVARTAL 2024 | 35101010 Real Estate Holding and Development | Ikke-informasjonspliktige pressemeldinger |
| 21 Oct 2024 15:27 CEST |
GraniteShares 3x Long Airbus Daily ETP | GraniteShares - Delisting ETPs - Euronext Paris | - | - |
| 21 Oct 2024 15:26 CEST |
Verd Boligkreditt AS | Verd Boligkreditt AS: Kvartalsrapport 3. kvartal 2024 | - | Annen informasjonspliktig regulatorisk informasjon |
| 21 Oct 2024 15:16 CEST |
SEABIRD EXPLORATION | Seabird Exploration Plc: Key dates to the NOK 0.25 per share cash distribution | 60101030 Oil Equipment and Services | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 15:15 CEST |
HUDDLESTOCK FINTECH | Share capital increase registered | 10101015 Software | Total number of voting rights and capital |
| 21 Oct 2024 15:14 CEST |
AKASTOR | Akastor ASA: HMH appoints Dan Rabun as Chairman of the Board of Directors | 60101030 Oil Equipment and Services | Non-regulatory press releases |
| 21 Oct 2024 15:04 CEST |
Mowi ASA | Shareholder Disclosure Notification | 45102010 Farming, Fishing, Ranching and Plantations | Major shareholding notifications |
| 21 Oct 2024 15:01 CEST |
EAM SOLAR AS | Shareholding disclosure - Nordnet AB (publ) | 30202000 Diversified Financial Services | Major shareholding notifications |
| 21 Oct 2024 15:00 CEST |
LOKOTECH GROUP AS | Link to fireside Chat Tomorrow, Tuesday 22nd of October 2024 at 13:30 CET | 10102010 Semiconductors | Non-regulatory press releases |
| 21 Oct 2024 14:53 CEST |
NHOA | NHOA : COMMUNIQUÉ DU 21 OCTOBRE 2024 | 60102020 Renewable Energy Equipment | Takeover bids |
| 21 Oct 2024 14:53 CEST |
NHOA | NHOA: Press Release Dated October 21, 2024 | 60102020 Renewable Energy Equipment | Takeover bids |
| 21 Oct 2024 14:42 CEST |
AEGA | Flaggemelding | 30202000 Diversified Financial Services | Flagging |
| 21 Oct 2024 14:42 CEST |
AEGA | Disclosure of shareholding | 30202000 Diversified Financial Services | Major shareholding notifications |
| 21 Oct 2024 14:33 CEST |
Oslofjord Sparebank | FOSB21 PRO - Nøkkelinformasjon ved innfrielse av deler av obligasjonslån | - | Annen informasjonspliktig regulatorisk informasjon |
| 21 Oct 2024 14:32 CEST |
Oslofjord Sparebank | Oslofjord Sparebank: Utstedelse av nytt senior usikret obligasjonslån | - | Annen informasjonspliktig regulatorisk informasjon |
| 21 Oct 2024 14:30 CEST |
INVENTIVA | Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024 | 20103010 Biotechnology | New |
| 21 Oct 2024 14:30 CEST |
INVENTIVA | Inventiva annonce un abstract « late breaker » sur l’essai clinique de Phase 2, LEGEND, combinant lanifibranor et empagliflozine, lors du Liver Meeting™ 2024 organisé par l’AASLD | 20103010 Biotechnology | New |
| 21 Oct 2024 14:00 CEST |
BN Bank ASA | Rentefastsettelse | - | Renteregulering |
| 21 Oct 2024 14:00 CEST |
Bergen Kommune | Rentefastsettelse | - | Renteregulering |
| 21 Oct 2024 14:00 CEST |
Kredittforeningen for Spareban | Rentefastsettelse | - | Renteregulering |
| 21 Oct 2024 14:00 CEST |
Kredittforeningen for Spareban | Rentefastsettelse | - | Renteregulering |